Eugene L. Palatulan
<p>The clinical focus is treating musculoskeletal injuries of people ages 13 and up, from weekend warriors to high-level athletes, those who are trying to remain active, and those who need help getting active. Particular interest in ultrasound-guided interventions and other available interventions for musculoskeletal joint pain.</p>
<p>Clinical research in musculoskeletal ultrasound. </p>
<p>Eugene Palatulan, MD, MA, is a sports medicine attending physician and Assistant Professor at Montefiore Einstein. Dr. Palatulan’s clinical focus is in treating musculoskeletal injuries of adolescents and adults of all levels of fitness and ability. He has particular interest in ultrasound-guided interventions and other available interventions for the treatment of musculoskeletal joint and tendinopathy pain.</p><p>After earning his Bachelor of Arts from Swarthmore College in 2005 and his Master of Arts at Columbia University in 2006, Dr. Palatulan spent several years in education, teaching high school biology in Bronx public high schools. He then pursued his medical education, first completing his post-baccalaureate with State University of New York at Buffalo in 2013, then pursuing his Doctor of Medicine at Albert Einstein College of Medicine at Yeshiva University, earning his medical degree in 2017. He completed his physical medicine and rehabilitation residency at NewYork-Presbyterian–Columbia/Cornell in 2021, and his sports medicine fellowship at the Hospital of the University of Pennsylvania in 2022. Throughout his career, he has enjoyed taking a holistic approach in the care of athletes and patients of all ages and abilities. He has been a team physician for a multitude of teams of all levels. He has worked as team physician for UPENN Football, Sprint Football, Men's and Women's Lacrosse, Men's and Women's Soccer and Men's and Women's basketball teams during his fellowship at PENN Sports Medicine. He worked closely and alongside head team physicians for the Philadelphia Eagles and Philadelphia Flyers in taking care of elite professional football and hockey players and was a critical team member in getting their pre-participation physicals completed. He was part of the team who took care of the Team USA Women's soccer team during their exhibition match in Philadelphia in 2022. He enjoys covering track and field and was assistant Chief Medical Officer for the annual PENN relays and worked as track captain throughout the event. The experience served him immensely as the covering medical director for the MAAC indoor Track and Field championships at the Nike Armory Indoor Track. Dr. Palatulan also enjoys mass coverage such as marathons and he has worked as a race captain for Broad Street Run and Philadelphia Love Marathon during sports fellowship year as well as the NYC Marathon going back to his years as a medical student (2013-2017), residency years (2018-2021) and he plans to keep on volunteering as an attending physician overlooking care and injury prevention in various medical tents along the marathon. He currently directs the Montefiore Einstein Adaptive Sports program serving a vast population in the Bronx and beyond of adaptive athletes and participants. He currently enjoys being a team physician for professional athletes, local high schools and colleges, including taking care of the New York City FC II in MLS Next Pro league team. He has been vetted as part of the network of USA Soccer Federation (USSF) Preferred Provider and is proud to have taken care of US Soccer athletes and elite soccer athletes. He is also excited to be a team physician and be part of the Cool Runnings journey with the Jamaica Bobsleigh Team.</p><p>Dr. Palatulan’s clinical research focuses on musculoskeletal ultrasound and care and management of athlete injuries and access to sports medicine particularly with pre-participation physicals/screening in high school and collegiate levels. He also takes a strong interest in injury prevention and delves into research on relative energy deficiency in sports (RED-S) and overuse injuries leading to tendinopathy and soft tissue injuries. His work has been shared through peer-reviewed journals, posters and abstracts.</p><p>Dr. Palatulan is a member of several professional organizations including the American Medical Society for Sports Medicine, the New York Society of Physical Medicine and Rehabilitation, the American Academy of Physical Medicine and Rehabilitation, and the Association of Academic Physiatrists.</p>
Mauricio Drummond, Jr.
Dr. Drummond’s clinical focus is in pediatric sports medicine with a special focus on knee pathology.
Dr. Drummond’s research interests include discoid meniscus, trochlear dysplasia, patellofemoral instability and ACL tears
<p>Mauricio Drummond Jr., MD, is an attending surgeon and Assistant Professor, Pediatrics and Orthopedic Surgery at Children’s Hospital at Montefiore. Dr. Drummond’s clinical focus is in pediatric sports medicine with a special focus on knee pathology. His interests include pediatric orthopedic surgery, complex pediatric and adolescent sports medicine, ACL, PCL and multiligament knee injuries, discoid meniscus, meniscus transplantation, patellofemoral instability, trochlear dysplasia, cartilage preservation and pediatric trauma and limb deformities.</p><p>In 1996, Dr. Drummond earned his Doctor of Medicine from Universidade Federal do Rio de Janeiro (Federal University of Rio de Janeiro) in Rio de Janeiro, Brazil. He completed his residency training at the same institution, and practiced as a knee specialist for more than 13 years in Brazil. In 2018, he came to the United States, completing an orthopedic surgery research fellowship at Cleveland Clinic Foundation in 2019 and an orthopedic sports medicine fellowship at the University of Pittsburgh Medical Center in 2020. He continued his postdoctoral training, completing his pediatric orthopedics and limb deformity fellowship at Montefiore Medical Center in 2021 and his pediatric orthopedics fellowship at Connecticut Children’s Medical Center in 2022.</p><p>Dr. Drummond’s research interests include discoid meniscus, trochlear dysplasia, patellofemoral instability and ACL tears. He has shared his work nationally and internationally through peer-reviewed journals and podium and poster presentations. He is also a reviewer for the <em>American Journal of Sports Medicine</em>.</p><p>Dr. Drummond is a member of several professional organizations including the International Society of Arthroscopy and Knee Orthopaedic Sports Medicine (ISAKOS), the American Orthopaedic Society for Sports Medicine (AOSSM), the Pediatric Orthopaedic Society of North America (POSNA) and the Pediatric Research in Sports Medicine Society (PRiSM).</p>
Rui Yang
<p>Dr. Yang earned his medical degree at Beijing Medical University in China followed by an orthopaedic residency at Peking University People’s Hospital in Beijing, China. Following his training in China, he came to the United States where he earned a Master’s degree in Biological Sciences from Hunter College at the City University of New York. Dr. Yang completed a second orthopaedic surgery residency at the University of Texas, in Houston and then he did a fellowship in Orthopaedic Oncology at Memorial Sloan-Kettering Cancer Center.</p>
<p>Dr. Yang specializes in the diagnosis and treatment of benign and malignant tumors in the musculoskeletal system. A multidisciplinary approach is emphasized in his practice. He performs surgery to remove the tumor fom the limb and pelvis, and rebuild them using techniques tailored for each individual patient. Dr. Yang is also interested in treating metastatic bony lesions originating from other parts of the body.</p>
<p>Dr. Yang has a strong interest in the research of musculoskeletal tumors. He has been studying the tumorigenesis of osteosarcoma and the genetic profile of the tumors as comparison to its normal counterpart tissues. He has also studied the mechanism of chemotherapy resistance in osteosarcoma and related signaling pathways, as well as novel strategies to overcome it in collaboration with the pediatric sarcoma teams.</p>
<p> </p>
Diagnosis and treatment of benign and malignant tumors in the musculoskeletal system, including metastatic bony lesions as well as primary tumors.<quillbot-extension-portal></quillbot-extension-portal>
Dr. Yang has a strong interest in the research of musculoskeletal tumors. He has been studying the tumor genesis of osteosarcoma and the genetic profile of the tumors as compared to normal counterpart tissues. He has also studied the mechanism of chemotherapy resistance in osteosarcoma and related signaling pathways, in addition to novel strategies to overcome it in collaboration with pediatric sarcoma teams.<quillbot-extension-portal></quillbot-extension-portal>
<p>1. Peer-reviewed Papers</p>
<p>1) <strong>Yang, R.</strong>, Piperdi, S., Zhang, Y., Neophytou, N., Zhu, W., Hoang, B.H., Mason, G., Geller, D., Dorfman, H,, Healey, J.H., Phinney, D.G., and Gorlick, R. Transcriptional Profiling Identifies the Signaling Axes of the Insulin Growth Factor and the Transforming Growth Factor-beta as involved in the Pathogenesis of Osteosarcoma. Clin Orthop Relat Res. 2015. PMID: 26463566</p>
<p>2) Nathan, S.S., Huvos, A.G., Casas-Ganem, J.E., <strong>Yang, R.,</strong> Linkov, I., Sowers, R., DiResta, G.R., Gorlick, R., Healey, J.H. Tumour interstitial fluid pressure may regulate angiogenic factors in osteosarcoma <a href="http://www.ncbi.nlm.nih.gov/pubmed/20052438">.</a> Ann Acad Med Singapore. 2009; 38(12):1041-7. PMID: 20052438</p>
<p>3) Li, N., <strong>Yang, R.</strong>, Zhang, W., Dorfman, H., Rao, P., and Gorlick, R. Genetically Transforming Human Mesenchymal Stem Cells to Sarcomas: changes in cellular phenotype and multilineage differentiation potential. Cancer. 2009; 115(20): 4795-806. PMID: 19593798</p>
<p>4) <strong>Yang, R</strong>., Piperdi, S., and Gorlick, R. Activation of the RAF/MEK/ERK pathway mediates apoptosis induced by chelerythrine in osteosarcoma. Clin Cancer Res. 2008;14(20): 6396-404. PMID: 18927278</p>
<p>5) <strong>Yang, R.</strong>, Qin, J., Hoang, B.H., Healey, J.H., and Gorlick, R. Polymorphisms and methylation of the reduced folate carrier in osteosarcoma. Clin Orthop Relat Res 2008;466:2046-51. PMID: 18528741</p>
<p>6) Nathan, S.S., Huvos, A.G., Casas-Ganem, J.E., <strong>Yang, R.</strong>, Linkov, I., Sowers, R., Diresta, G.R., Gorlick, R., and Healey, J.H. Tumor interstitial fluid pressure may regulate angiogenic factors in osteosarcoma. J Orthop Res 2008;26:1-6. PMID: 18473395</p>
<p>7) <strong>Yang, R.</strong>, Li, W.W., Hoang, B.H., Kim, H., Banerjee, D., Kheradpour, A., Healey, J.H., Meyers, P.A., Bertino, J.R., and Gorlick, R. Quantitative correlation between promoter methylation and messenger RNA levels of the reduced folate carrier. BMC Cancer 2008;8:124. PMID: 18452618</p>
<p>8) <strong>Yang, R.</strong>, Kolb, E.A., Qin, J., Chou, A., Sowers, R., Hoang, B., Healey, J.H., Huvos, A.G., Meyers, P.A. and Gorlick, R. The folate receptor alpha is frequently overexpressed in osteosarcoma samples and plays a role in the uptake of the physiologic substrate 5-methyltetrahydrofolate. Clin Cancer Res 2007;13:2557-67. PMID: 17473184</p>
<p>9) <strong>Yang, R.</strong>, Hoang, B.H., Kubo, T., Kawano, H., Chou, A., Sowers, R., Huvos, A.G., Meyers, P.A., Healey, J.H. and Gorlick, R. Over-expression of parathyroid hormone Type 1 receptor confers an aggressive phenotype in osteosarcoma. Int J Cancer 2007;121:943-54. PMID: 17410535</p>
<p>10) Laverdiere, C., Hoang, B.H., <strong>Yang, R.</strong>, Sowers, R., Qin, J., Meyers, P.A., Huvos, A.G., Healey, J.H. and Gorlick, R. Messenger RNA expression levels of CXCR4 correlate with metastatic behavior and outcome in patients with osteosarcoma. Clin Cancer Res 2005;11:2561-7. PMID: 15814634</p>
<p>11) Nathan, S.S., DiResta, G.R., Casas-Ganem, J.E., Hoang, B.H., Sowers, R., <strong>Yang, R.</strong>, Huvos, A.G., Gorlick, R. Elevated physiologic tumor pressure promotes proliferation and chemosensitivity in human osteosarcoma. Clin Cancer Res 2005;11:2389-97. PMID: 15788690</p>
<p>12) Flintoff, W.F., Sadlish, H., Gorlick, R., <strong>Yang, R.</strong>, Williams, F.M. Functional analysis of altered reduced folate carrier sequence changes identified in osteosarcomas. Biochim Biophys Acta 2004;1690:110-7. PMID: 15469899</p>
<p>13) Hoang, B.H., Kubo, T., Healey, J.H., <strong>Yang, R.</strong>, Nathan, S.S., Kolb, E.A., Mazza, B., Meyers, P.A. and Gorlick, R. Dickkopf 3 inhibits invasion and motility of Saos-2 osteosarcoma cells by modulating the Wnt-beta-catenin pathway. Cancer Res 2004;64:2734-9. PMID: 15087387</p>
<p>14) Hoang, B.H., Kubo, T., Healey, J.H., Sowers, R., Mazza, B., <strong>Yang, R.</strong>, Huvos, A.G., Meyers, P.A. and Gorlick, R. Expression of LDL receptor-related protein 5 (LRP5) as a novel marker for disease progression in high-grade osteosarcoma. Int J Cancer 2004;109:106-11. PMID: 14735475</p>
<p>15) <strong>Yang, R.</strong>, Sowers, R., Mazza, B., Healey, J.H., Huvos, A., Grier, H., Bernstein, M., Beardsley, G.P., Krailo, M.D., Devidas, M., Bertino, J.R., Meyers, P.A. and Gorlick, R. Sequence alterations in the reduced folate carrier are observed in osteosarcoma tumor samples. Clin Cancer Res 2003;9:837-44. PMID: 12576457</p>
<p> </p>
<p>2. Book Chapters</p>
<p align="left">1) Orthopedic Oncology. Editor: Xun, W.P., Feng, C.H. People’s Military Medical Publisher.</p>
<p>(ISBN: 7-80157-159-2), 2001.</p>
<p>2) Review of Surgery: A Guiding Book for Medical Students. Section of Orthopedics. Editor: Jiang, B.G. Beijing Medical University Publisher. (ISBN: 7-81034-946-5), 1999.</p>
<p>Dr. Yang is a fellowship-trained orthopedic surgeon recognized for his multidisciplinary approach to the diagnosis and treatment of benign and malignant tumors in the musculoskeletal system, including metastatic bony lesions as well as primary tumors. He also serves as an Assistant Professor at our Albert Einstein College of Medicine.</p><p>Dr. Yang earned his medical degree at Beijing Medical University in China followed by an orthopedic residency at Peking University People?s Hospital in Beijing, China. Following his training in China, he came to the United States where he earned a master?s degree in biological sciences from Hunter College at the City University of New York. Dr. Yang completed a second orthopedic surgery residency at the University of Texas, in Houston, followed by a fellowship in orthopedic oncology at Memorial Sloan-Kettering Cancer Center.</p><p>Dr. Yang has a strong interest in the research of musculoskeletal tumors. He has been studying the tumor genesis of osteosarcoma and the genetic profile of the tumors as compared to normal counterpart tissues. He has also studied the mechanism of chemotherapy resistance in osteosarcoma and related signaling pathways, in addition to novel strategies to overcome it in collaboration with pediatric sarcoma teams.</p>
Shudan Wang
<p class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; text-indent: .5in; line-height: normal;"><span style="font-size: 12.0pt; font-family: 'Arial',sans-serif; mso-fareast-font-family: 'Times New Roman';">Dr. Wang is an Attending Physician in the Division of Rheumatology at Montefiore Medical Center, and an Assistant Professor of Medicine at Albert Einstein College of Medicine. She is board certified in both internal medicine and rheumatology and currently sees patients at the Montefiore Westchester Practice at Taxter Road. Dr. Wang has an expertise in lupus and lupus related kidney disease. She is also skilled to see a wide range of other rheumatologic diseases, including but not limited to antiphospholipid syndrome, Sjogren’s syndrome, rheumatoid arthritis, <span style="color: black;">spondyloarthropathy</span> and psoriatic arthritis, vasculitis, myositis, polymyalgia rheumatica, scleroderma and osteoarthritis.</span></p>
<p class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; text-indent: .5in; line-height: normal;"><span style="font-size: 12.0pt; font-family: 'Arial',sans-serif; mso-fareast-font-family: 'Times New Roman';">Dr. Wang graduated from McGill University with a major in Physiology and Statistics in 2009. Dr. Wang received her medical degree from Rutgers New Jersey Medical School in 2013. She subsequently completed her internal medicine residency training at New York Presbyterian Hospital Cornell in 2016, followed by a fellowship in Rheumatology at New York University Hospital in 2018. Dr. Wang obtained a MS in clinical research from the Albert Einstein Clinical Research Training Program in 2021. </span></p>
<p class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; text-indent: .5in; line-height: normal;"><span style="font-size: 12.0pt; font-family: 'Arial',sans-serif; mso-fareast-font-family: 'Times New Roman';">Dr. Wang's research interest is in lupus, focused on the role of the complement system in lupus related kidney disease. Dr. Wang is supported by the NIH KL2 Mentored Clinical Research Scholar Grant and the Rheumatology Research Foundation K-Bridge Grant to investigate complement biomarkers in lupus nephritis using various translational approaches including immunohistochemistry, urine proteomics and single cell RNA sequencing. Dr. Wang has experience working with large cohorts and databases, recruiting patients for the Einstein Rheumatic Disease Registry and serve as sub-investigator for lupus clinical trials. She has published first author papers in prestigious journals, presented her academic work at national meetings and served on NIH and CDC study sections. She was recognized by American College of Rheumatology as a Distinguished Fellow nationally for translational research and clinical excellence in 2018.</span></p>
<p class="MsoNormal" style="mso-outline-level: 1;"><strong><span style="font-family: 'Arial',sans-serif;">Wang Shudan</span></strong><span style="font-family: 'Arial',sans-serif;">, Wu M, Chiriboga L, Zeck B, Goilav B, Wang Shuwei, Jimenez-Londono A, </span><span style="font-family: 'Arial',sans-serif;">Putterman C, Schwartz D, Pullman J, Broder A, HM Belmont. Membrane Attack Complex (MAC) Deposition in Renal Tubules is Associated with Interstitial Fibrosis/Tubular Atrophy: A Pilot Study. <em>Lupus Science & Medicine. </em>2022 Jan; 9(1). </span></p>
<p class="MsoNormal" style="mso-outline-level: 1;"><span style="font-family: 'Arial',sans-serif;">Tagoe, CE, Wang W, <strong>Wang S</strong>, Barbour K. Association of anti-thyroid antibodies with radiographic knee osteoarthritis and chondrocalcinosis: a NHANES III study. <em>Therapeutic Advances in Musculoskeletal Disease. </em>2021 Aug 4; 13. </span></p>
<p class="MsoNormal" style="mso-outline-level: 1;"><span style="font-family: 'Arial',sans-serif;">Guerrero, MS, Londono, A, Dobrowolski C, Mowrey WB, Goilav B, <strong>Wang S</strong>, Broder A. Systemic Lupus Erythematosus Activity and Hydroxychloroquine Use Before and After End-Stage Renal Disease. <em>BMC Nephrology</em>. 2020 Oct 28; 21(1): 450.</span></p>
<p class="MsoNormal"><strong style="mso-bidi-font-weight: normal;"><span style="font-family: 'Arial',sans-serif;">Wang S, </span></strong><span style="font-family: 'Arial',sans-serif;">Wu M, Pillinger MH, Krasnokutsky, S, and Barbour K. The Association between Asymptomatic Hyperuricemia and Knee Osteoarthritis: Data from Third National Health and Nutrition Examination Survey. <a title="Osteoarthritis and cartilage." href="https://www.ncbi.nlm.nih.gov/pubmed/?term=The+Association+between+Asymp… class="highlight"><em><span style="color: windowtext; text-decoration: none; text-underline: none;">Osteoarthritis</span></em></span><em> Cartilage.</em></a> 2019 Sep;27(9):1301-1308. </span></p>
<p class="MsoNormal"><strong style="mso-bidi-font-weight: normal;"><span style="font-family: 'Arial',sans-serif; color: black;">Wang S, </span></strong><span style="font-family: 'Arial',sans-serif; color: black;">Wu M, Chiriboga L, Zeck B, HM Belmont. Membrane Attack Complex (MAC) Deposition in Lupus Nephritis is Associated with Hypertension and Poor Clinical Response to Treatment. <em style="mso-bidi-font-style: normal;">Semin Arthritis Rheum. 2018; 48(2): 256-262.</em><span style="mso-spacerun: yes;"> </span></span></p>
<p class="MsoNormal"><strong style="mso-bidi-font-weight: normal;"><span style="font-family: 'Arial',sans-serif; color: black;">Wang S, </span></strong><span style="font-family: 'Arial',sans-serif; color: black;">Broder N, Marchetta P, Nowatzky J. Myelodysplastic syndrome presenting as a Behcet’s like syndrome with aortitis. <em style="mso-bidi-font-style: normal;">BMJ Case Rep. 2018 March 15. </em><span style="mso-spacerun: yes;"> </span></span></p>
<p class="MsoNormal"><span style="font-family: 'Arial',sans-serif; color: black;">Oshima-Takane Y, <strong style="mso-bidi-font-weight: normal;">Wang S</strong>, Takane M and Takane, Y. T</span><span style="font-family: 'Arial',sans-serif;">he Acquisition of Personal Pronouns in English: Neural Network Stimulations. S<em style="mso-bidi-font-style: normal;">tudies in Language Sciences. 2014, Jan: 13 (53-69).</em></span></p>
<p class="MsoNormal" style="margin-right: 24.0pt;"><span style="font-family: 'Arial',sans-serif;">Sleat DE, Ding L, <strong style="mso-bidi-font-weight: normal;">Wang S, </strong>Zhao C, Wang Y, Zheng H, Moore DF, Sims KB, Lobel P<strong style="mso-bidi-font-weight: normal;">. </strong>Mass spectrometry-based protein profiling to determine the cause of lysosomal storage disease of unknown etiology. <em style="mso-bidi-font-style: normal;">Mole Cell Proteomics</em>. <em style="mso-bidi-font-style: normal;">2009 Jul; 8(7): 1708-18.</em> </span></p>
<p class="MsoNormal" style="margin-right: 24.0pt; text-indent: -.25in;"><strong style="mso-bidi-font-weight: normal;"><span style="mso-bidi-font-family: Arial;"> </span></strong></p>
Stanley F. Wainapel
<p>My primary areas of clinical and research interest are: Complementary/Alternative Medicine (CAM); physical disability among physicians and medical students; medical problems in musicians; ethical aspects of rehabilitation research; and disability in the novels of Charles Dickens. My long-term research goal is to write a book on Dickens and Medicine. </p>
<span class="TextRun SCXW33707701 BCX8" data-contrast="none" lang="EN-US" style="white-space:pre-wrap;margin:0px;padding:0px;user-select:text;-webkit-user-drag:none;-webkit-tap-highlight-color:transparent;font-size:11pt;line-height:16px;font-family:Arial, Arial_EmbeddedFont, Arial_MSFontService, sans-serif;font-variant-ligatures:none !important;" xml:lang="EN-US">Dr. Wainapel has a wide range of clinical interests including geriatric rehabilitation, complementary/alternative therapies for pain management, vision rehabilitation, and performing arts medicine</span><span class="EOP SCXW33707701 BCX8" data-ccp-props="{"201341983":0,"335559739":0,"335559740":240}" style="white-space:pre-wrap;margin:0px;padding:0px;user-select:text;-webkit-user-drag:none;-webkit-tap-highlight-color:transparent;font-size:11pt;line-height:16px;font-family:Arial, Arial_EmbeddedFont, Arial_MSFontService, sans-serif;"> </span>
<span class="TextRun SCXW12926019 BCX8" data-contrast="none" lang="EN-US" style="margin:0px;padding:0px;user-select:text;-webkit-user-drag:none;-webkit-tap-highlight-color:transparent;white-space:pre-wrap;background-color:#ffffff;font-size:11pt;line-height:16px;font-family:Arial, Arial_EmbeddedFont, Arial_MSFontService, sans-serif;font-variant-ligatures:none !important;" xml:lang="EN-US"><span class="NormalTextRun SCXW12926019 BCX8" style="margin:0px;padding:0px;user-select:text;-webkit-user-drag:none;-webkit-tap-highlight-color:transparent;"></span></span>Vision rehabilitation, the history of Physical Medicine and Rehabilitation, physical disabilities among physicians, and bioethics are the main focuses of Dr. Wainapel’s research.<span 201341983":0,"335559739":0,"335559740":240}"="" class="EOP SCXW12926019 BCX8" data-ccp-props="{" style="margin:0px;padding:0px;user-select:text;-webkit-user-drag:none;-webkit-tap-highlight-color:transparent;white-space:pre-wrap;background-color:#ffffff;font-size:11pt;line-height:16px;font-family:Arial, Arial_EmbeddedFont, Arial_MSFontService, sans-serif;"></span><quillbot-extension-portal></quillbot-extension-portal>
<p>Stanley F. Wainapel, MD, MPH, is Clinical Director, Physical Medicine and Rehabilitation at Montefiore, and Professor of Clinical Physical Medicine and Rehabilitation at our Albert Einstein College of Medicine. Since joining the Montefiore team, his clinical focus has been general rehabilitation, vision rehabilitation, chronic pain, and acupuncture.</p><p>In 1970, Dr. Wainapel received his Bachelor of Arts after completing a 6-year medical program at Boston University. During this time, he also attended Boston University School of Medicine, where he received his Doctor of Medicine in 1970. He began his postgraduate training in 1970 with a year-long internship in medicine at Genessee Hospital, followed by a residency at Albert Einstein College of Medicine, which he completed in 1974. In 1982, Dr. Wainapel his Master of Public Health in 1989 from Boston University.</p><p>Vision rehabilitation, the history of Physical Medicine and Rehabilitation, physical disabilities among physicians, and bioethics are the main focuses of Dr. Wainapel’s research. His work has been presented nationally at many guest lectures and published in numerous books and textbooks.</p><p>From 1982 to 1985, Dr. Wainapel was President of the American Society of Handicapped Physicians. He also spent a year as President of the New York Society of Physical Medicine and Rehabilitation in 1991. Dr. Wainapel is a diplomat of the National Board of Medical Examiners and the American Board of Physical Medicine and Rehabilitation.</p>
Pramod B. Voleti
Specializes in a wide variety of conditions involving the shoulder, elbow, and knee with a special interest and expertise in sports medicine, shoulder instability, rotator cuff tears, elbow tendinopathy, knee ligament reconstruction, meniscal pathology and cartilage restoration.<quillbot-extension-portal></quillbot-extension-portal>
Orthopedic Surgery<quillbot-extension-portal></quillbot-extension-portal>
<p>Pramod B. Voleti, MD, specializes in a wide variety of conditions involving the shoulder, elbow, and knee with a special interest and expertise in sports medicine, shoulder instability, rotator cuff tears, elbow tendinopathy, knee ligament reconstruction, meniscal pathology and cartilage restoration.</p><p>Dr. Voleti graduated from Princeton University with high honors. He then received his medical degree from SUNY Downstate College of Medicine. During medical school, he was elected to the Alpha Omega Alpha (AOA) Honor Society and earned the Christopher Pavlides Award for Excellence in Orthopedic Surgery. Dr. Voleti completed his orthopedics residency at the University of Pennsylvania, which included clinical rotations at the Hospital of the University of Pennsylvania, Pennsylvania Hospital, Penn Presbyterian Medical Center, Children?s Hospital of Philadelphia, and Philadelphia VA Medical Center, in addition to a one-year research fellowship in the renowned McKay Orthopedic Research Laboratory. He completed an additional fellowship training in sports medicine and shoulder surgery at the Hospital for Special Surgery. During this fellowship, he provided medical coverage for the Brooklyn Nets, Iona College Athletics, and high school football teams in the Public Schools Athletic League.</p><p>His research has been published in over 30 peer-reviewed publications, five book chapters, and thirty presentations at regional, national, and international meetings. He is a member of the American Academy of Orthopedic Surgery, the Arthroscopy Association of North America and the American Orthopedic Society for Sports Medicine.</p>
Mark A. Thomas
Clement E. Tagoe
<p>Dr. Clement Tagoe obtained his medical degree from the University of Ghana Medical School, Ghana, and a PhD in biochemistry from the University of Leeds, UK. His basic science research interests included the study of the role of annexins in cell function and rheumatic diseases, and subsequently the mechanisms of disease in transthyretin amyloidosis using several animal models of transthyretin amyloidosis. His clinical work in the area of transthyretin amyloidosis has greatly illuminated our understanding of the form of amyloidosis associated with the Transthyretin V122I (pV142I) mutation, which is found in about 3 to 4% of African Americans. His current work focuses on the role of autoimmune diseases in fibromyalgia and chronic widespread pain, and in particular the association of these syndromes with autoimmune thyroid disease (AITD). His work also explores the other musculoskeletal and rheumatic manifestations of autoimmune thyroid disease, including the association with peripheral osteoarthritis and spinal osteoarthritis. These autoimmune syndromes can occur in the absence of thyroid dysfunction and are of particular interest to physicians and patients because AITD is by far the commonest autoimmune disease.</p>
<p class="MsoNormal"><strong>Selected Bibliography</strong></p>
<p class="MsoNormal">1. Clement E. Tagoe, Tejas Sheth, Eugeniya Golub, Karen Sorensen (2019) Rheumatic associations of autoimmune thyroid disease: a systematic review Clin Rheumatol. 2019 Jul;38(7):1801-1809., (1-9) DOI: 10.1007/s10067-019-04498-1</p>
<p class="MsoNormal">2. Kavisha Patel, Clement Tagoe, Phyllis Bieri, Karen Weidenheim & James M. Tauras (2018): A case of transthyretin amyloidosis with myopathy, neuropathy, and cardiomyopathy resulting from an exceedingly rare mutation transthyretin Ala120Ser (c.418G > T, p.Ala140Ser), Amyloid, DOI: 10.1080/13506129.2018.1491398</p>
<p class="MsoNormal">3. Daniel R. Jacobson, Alice A. Alexander, Clement Tagoe, W. Timothy Garvey, Scott M.</p>
<p class="MsoNormal">Williams, Sara Tishkoff, David Modiano, Sodiomon Bienvenu Sirima, Issa Kalidi, Toure A, & Joel N. Buxbaum. The Prevalence and Distribution of the Amyloidogenic Transthyretin (TTR) V122I Allele in Africa Molecular Genetics & Genomic Medicine Epub 14 July, 2016 DOI: 10.1002/mgg3.231</p>
<p class="MsoNormal">4. Asha Shrestha, Hillel W. Cohen, Clement E. Tagoe. Association of Autoimmune Thyroid Disease With A Higher Frequency Of Spinal Degenerative Disc Disease Clin Exp Rheumatol. 2016 Mar-Apr;34(2):296-302. Epub 2016 Feb 9. PMID: 26885680</p>
<p class="MsoNormal">5. Tagoe CE, Zezon A, Khattri S. Rheumatic manifestations of autoimmune thyroid disease: the other autoimmune disease. J Rheumatol. 2012 Jun;39(6):1125-9. Epub 2012 Apr 15.</p>
<p> </p>
<p class="MsoNormal"> </p>
<p> </p>